Advertisement
J. Lipid Res.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1194/jlr.M900151-JLR200 on May 11, 2009

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
M900151-JLR200v1
50/9/1889    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Wool, G. D.
Right arrow Articles by Getz, G. S.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wool, G. D.
Right arrow Articles by Getz, G. S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Journal of Lipid Research, Vol. 50, 1889-1900, September 2009
Copyright © 2009 by American Society for Biochemistry and Molecular Biology

An apoA-I mimetic peptide containing a proline residue has greater in vivo HDL binding and anti-inflammatory ability than the 4F peptide

Geoffrey D. Wool*, Tomas Vaisar{dagger}, Catherine A. Reardon* and Godfrey S. Getz*,1

* Department of Pathology, University of Chicago, Chicago, IL
{dagger} Department of Medicine, University of Washington, Seattle, WA

1 To whom correspondence should be addressed. e-mail: g-getz{at}uchicago.edu

Modifying apolipoprotein (apo) A-I mimetic peptides to include a proline-punctuated {alpha}-helical repeat increases their anti-inflammatory properties as well as allows better mimicry of full-length apoA-I function. This study compares the following mimetics, either acetylated or biotinylated (b): 4F (18mer) and 4F-proline-4F (37mer, Pro). b4F interacts with both mouse HDL (moHDL) and LDL in vitro. b4F in vivo plasma clearance kinetics are not affected by mouse HDL level. Administration of biotinylated peptides to mice demonstrates that b4F does not associate with lipoproteins smaller than LDL in vivo, though it does associate with fractions containing free hemoglobin (Hb). In contrast, bPro specifically interacts with HDL. b4F and bPro show opposite binding responses to HDL by surface plasmon resonance. Administration of acetylated Pro to apoE–/– mice significantly decreases plasma serum amyloid A levels, while acetylated 4F does not have this ability. In contrast to previous reports that inferred that 4F associates with HDL in vivo, we systematically examined this potential interaction and demonstrated that b4F does not interact with HDL in vivo but rather elutes with Hb-containing plasma fractions. bPro, however, specifically binds to moHDL in vivo. In addition, the number of amphipathic {alpha}-helices and their linker influences the anti-inflammatory effects of apoA-I mimetic peptides in vivo.

Supplementary key words apolipoprotein A-I • high density lipoprotein • synthetic peptides • cholesterol • inflammation • oxidation

Abbreviations: apo, apolipoprotein; AUC, area under the curve; b4F, biotinylated 4F; bPro, biotinylated Pro; DMF, dimethylformamide; ECL, enhanced chemiluminescence; FPLC, fast protein liquid chromatography; Hb, hemoglobin; HDL-C, HDL cholesterol; HRP, horseradish peroxidase; huHDL, human HDL; IP, intraperitoneal; MDA, malondialdehyde; moHDL, mouse HDL; moLDL, mouse LDL; Pro, 4F-proline-4F; RU, response unit; SAA, serum amyloid A; SPR, surface plasmon resonance; TBARS, thiobarbituric acid-reactive substance; TC, total cholesterol; TEP, 1,1,3,3-tetraethoxypropane


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Copyright © 2009 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement